-
 Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB): The Target Market for Spider Silk
The market Kraig Biocraft Laboratories has targeted is generally referred to as the “technical textiles” market. This market encompasses a wide range of products that are used for a large number of different types of applications. The products sold into the technical textiles market are either finished products in themselves or are used as components to produce other products.
The specific sector of the technical textiles market targeted by the company is known as the high-performance fibers market and can be broken down into two main areas: Aramid fibers, the best known of these fibers being DuPont’s Kevlar which produces more than $5 billion in annual sales; and ultra-high molecular weight polyethylene fibers, such as Spectra, which is produced by Honeywell International, Inc.
The worldwide market for these fibers and other high performance technical fibers is massive. It is estimated that this market generates $90 billion per year, with the United States accounting for more than half of the market. The industry has experienced significant growth over the past 10 years and is expected to continue growing at a similarly robust rate over the coming years.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Reports Noteworthy Progress in Development of Site Specific Genetic Recombination
Kraig Biocraft Laboratories, Inc. announced this morning that Dr. Fraser’s team has “made significant progress on developing enzymes and strategies for conducting site specific genetic recombination in silkworm.”
“In the Company’s view, the development of this particular gene splicing technology is the key to unlocking the tremendous commercial potential of spider silks and other recombinant polymers,” stated Kraig’s CEO, Kim K. Thompson. “Dr. Fraser’s report of this news from the laboratory is the culmination of years of scientific effort. It is a huge milestone on the path to commercialization,” continued Thompson.
“We believe that we are the only people who have this capability at this time.” Dr. Fraser added.
Dr. Fraser’s team of research scientists, working within University of Notre Dame laboratories, has made several significant advancements over the last four or five months. This most recent announcement follows shortly after the company’s report that it had performed approximately five thousand genetic insertions, and that it had achieved the activation of fluorescent marker gene sequences which the researchers incorporated into spider silk DNA packets.
Site specific genetic recombination allows for the genetic targeting of a specific location on a specific chromosome. This ability is potentially vital to the company’s work because of the strong influence of what geneticists call “location effects.” These effects do not result from the coding of a specific gene, but from the location of that gene on a specific chromosome.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Board of Directors Approves Stock Dividend
Today, Kraig Biocraft Laboratories, Inc. announced that its Board of Directors has approved a stock dividend. According to the press release, shareholders of record as of the close of business on the record date will be issued nine additional shares for each share of Common Stock held.
CEO Kim K. Thompson commented, “This stock dividend is intended to lay the groundwork for the growth of the Company. It is part of our ongoing efforts to improve trading liquidity, broaden ownership, promote capital investment and enhance shareholder value. This action is enabled by the Company’s continued success in the laboratory and is consistent with the Board’s commitment to take actions designed to create a wider distribution of the Company’s stock.”
The Board of Directors has directed the company’s management to speak with market oversight authorities and its transfer agents as soon as is practical to designate a record date.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Rewarding Shareholders with Dividends
Dividends, regarded as a key indicator of a company’s financial health and contributing significantly to a stock investor’s long-term wealth, can be a crucial factor in evaluating a company for long-term investment. In today’s market, it’s even more critical to build a portfolio of quality companies with the financial strength necessary to issue dividends.
A recent research study found that, in the year after large-cap companies raised their dividends, they outperformed their peers (based on total return) by an average of 1.8 percentage points. Those that began paying dividends for the first time, or reinstated them after a lapse, outperformed their peers by 2.7 percentage points. Small-cap and Micro-cap companies have also issued various types of dividends to reward existing investors as well as attract new investors.
Although the dividend payable dates for these companies have passed, some of the recently announced micro-cap dividends include EvergreenBancorp, Inc.’s (OTCBB: EVGG) 5% stock dividend and cash dividend of $0.035; Colorado Goldfields Inc.’s (OTCBB: CGFI) 30% stock dividend; and American Green Group, Inc.’s (PINKSHEETS: AMNE) preferred stock dividend. Companies that have upcoming dividend payable dates include United Community Banks, Inc.’s (NASDAQ: UCBI) quarterly dividend that will be paid in common stock on April 1, 2009; Syndication Inc.’s (PINKSHEETS: SYNJ) upcoming 5% stock dividend to be paid on April 29, 2009; and TIB Financial Corp.’s (NASDAQ: TIBB) stock dividend that is payable on April 10, 2009.
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), a development-stage biotechnology company focused on developing high performance polymers and technical fibers, is a company we’re closely watching that recently approved a stock dividend. Shareholders of record, as of the close of business on the record date, will be issued nine additional shares for each share of Common Stock held. The company has made significant progress in their labs over the past few months and is closer than ever to finding a solution for producing commercial quantities of spider silk, a super-strength fiber that has an unparalleled capacity to absorb energy and dissipate it in a very controlled manner.
From January 1926 through December 2004, the annualized total return for the S&P 500 was 10.46% per year. Surprisingly, the dividend component consisted of 41.28% of that return. With dividends making such a profound impact on investors’ long-term returns, it is crucial that investors take dividends into consideration when making investments.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Achieves Higher Levels of Transient Expression of Targeted DNA
Kraig Biocraft Laboratories, Inc. was very pleased to announce this morning that scientists working in the company’s sponsored research program at the University of Notre Dame have significantly increased the number and proportion of DNA insertions that yield transient expression of the company’s targeted marker protein.
“These results, which are occurring in the latest generation of genetic insertions performed in the laboratory, are very exciting, and we believe that it is further evidence that the research team is on the right track,” commented CEO Kim K. Thompson.
This increase is in both absolute numbers and in the percentage of insertions, which ultimately result in the expression. This morning’s news follows closely on the heels of other progress reports, announcing to investors the significant achievements made over the last six months.
“This is the first time we have seen the number of DNA insertions yielding transient expression reach the triple digits. We do seem to be in a state of acceleration in terms of the pace of laboratory achievement,” added Mr. Thompson.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc.’s (KBLB.OB) Innovative Approach to the Technical Fibers Market
In a world where the value of a company is increasingly based upon its intellectual capital, Kraig Biocraft Laboratories appears to have a solid future. That’s because the Michigan-based biotechnology development company has a lock on a very good idea, an idea that could be the key to a market representing billions of dollars in estimated annual sales.
The market is the resilient technical fibers market, currently controlled by Kevlar, DuPont’s super tough para-aramid synthetic fiber. Today Kevlar is used in body armor, bicycle tires, racing sales, audio equipment, buildings, and a host of other applications where the strength to weight ratio must be exceptional. Sales of Kevlar approach $5 billion annually.
But now there is a new fiber knocking on the door that has significant advantages over Kevlar. The fiber is spider silk, more elastic that Kevlar, hypoallergenic and biodegradable, and with the highest strength to weight ratio known, other than perhaps single wall carbon nanotubes. Kraig Biocraft’s great idea is how to produce it. You can’t just round up a billion spiders and let them do their thing, primarily because they tend to attack each other. Nature’s best known silk producer, the silkworm, doesn’t have this problem, but the silkworm doesn’t product spider silk.
Kraig’s brilliant answer to the problem was to get together some of the best minds in the field of genetics, and have them come up with a way to modify silkworms so that they produce spider silk and other specialized proteins. Using some of the most advanced genetic engineering techniques, Kraig has managed to insert the spider’s silk-producing genetic codes into silkworms, and has now verified the efficacy of the transfer. With each new accomplishment, the company appears closer to its goal of creating transgenic silkworms capable of producing significant amounts of spider silk.
However, it’s not that Kraig Biocraft plans on going into large scale production. For Kraig, it’s all about the intellectual capital, the golden key that a more production minded enterprise could use to unlock untold future wealth. That’s why more and more people have their eye on the company, and why a relatively small company is seen to have a very big potential value.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Updates Investors on Stock Dividend Progress
Today before the bell, Kraig Biocraft told investors that it has instructed its attorneys to contact FINRA, the largest independent securities regulator in the US, to achieve clearance to announce the record date for its stock dividend. As announced earlier, the Board of Directors approved the dividend that would give shareholders nine additional shares for each share of common stock held.
“We will keep our shareholders informed both through our website, Kraig Biocraft and through public press releases,” commented CEO Kim Thompson. “When we receive clearance from FINRA for the record date we will make that announcement on the investor relations page of the Company’s website.”
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories (KBLB.OB) is on the Cusp of Potentially Unlocking Hundreds of Millions
Those of us who were around in the 1970’s remember watching The Six Million Dollar Man. In this fictional series, Steve Austin was an astronaut that met with an accident and the government was able to rebuild him to be better, stronger, and faster. If you take a look at what Kraig Biocraft Laboratories is doing, the obscure theme from The Six Million Dollar Man seems to resonate. Kraig Biocraft is taking a naturally occurring element from nature and is on a mission to make it better, stronger, and faster.
Kraig Biocraft, an emerging biotech company, has brought together some of the world’s best researchers to take this technology and collaborate on how to make spider silk’s better and stronger capabilities available commercially. The company is also reaching out to developing minds by launching the Kraig Research Initiative, which is a work program that funds university scientists and laboratories. As part of the program, Kraig Biocraft is given the right to license any intellectual property developed at the university in the genetics and genetic engineering fields. The company hopes to produce significant quantities of spider silk that can be used in a number of commercial and consumer applications.
But who would use spider silk? Because spider silk is strong and lightweight, the aerospace industry is a niche that should have a whole host of applications for the material. Airplanes are constantly under pressure on the ground and in the air, so the inclusion of such a resilient material like spider silk would only benefit the aircraft. Silk can also be used to strengthen cables and components used by the power, water, and communication industries at critical junctions.
The most significant use of the spider silk would be its use in safety equipment used by the military and police departments. Most enforcement agencies use vest and body armor that is reinforced by Kevlar, which can be bulky and heavy. The incorporation of spider silk would significantly reduce the weight of the protective gear, thus lessen the strain on its wearer.
Kraig Biocraft has built a strong intellectual community capable of developing the genetic technology to achieve its goal to produce commercial quantities of spider silk. According to Emerging Growth Research if “the company should achieve its goal … we believe the technology will likely immediately be worth at least several hundred million dollars.”
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Reports Record Date for Stock Dividend
Kraig Biocraft Laboratories, Inc. announced that the record date for the recently declared stock dividend will be April 27, 2009. Shareholders of record as of the close of business on this date will be issued nine additional shares for each share of Common Stock held.
CEO Kim K. Thompson recently commented, “This stock dividend is intended to lay the groundwork for the growth of the Company. It is part of our ongoing efforts to improve trading liquidity, broaden ownership, promote capital investment and enhance shareholder value. This action is enabled by the Company’s continued success in the laboratory and is consistent with the Board’s commitment to take actions designed to create a wider distribution of the Company’s stock.”
This stock dividend declaration follows the announcements over the last several months of significant increases in laboratory productivity. Kraig Biocraft believes their remarkable success is the direct result of the company’s successful efforts to recruit highly talented scientists and researchers.
-
Re: Kraig Biocraft Laboratories Inc. - KBLB
Don’t Miss Kraig Biocraft Laboratories, Inc.’s (KBLB.OB) Dividend!
Last week Kraig Biocraft Laboratories announced that shareholders of record as of the close of business on April 27 will be issued nine additional shares for each share of stock held. However, to be the legal owner on the record date you must buy the stock at least three business days before the record date. Today is exactly three business days away from the deadline.
Commenting on the dividend, CEO Kim K. Thompson recently stated, “This stock dividend is intended to lay the groundwork for the growth of the Company. It is part of our ongoing efforts to improve trading liquidity, broaden ownership, promote capital investment and enhance shareholder value. This action is enabled by the Company’s continued success in the laboratory and is consistent with the Board’s commitment to take actions designed to create a wider distribution of the Company’s stock.”
|
Checking For Related Data... |
View Profile
View Forum Posts
Private Message
Visit Homepage
Reply With Quote
Posting Permissions
Bookmarks